India’s drug regulator approved a three-dose, DNA-based COVID-19 vaccine (BBC) made by Zydus Cadila for emergency use. The first such vaccine approved in the world, an interim study showed it prevented symptomatic disease in 66 percent of those vaccinated, the drugmaker said.
